{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "GSHD",
  "name": "Goosehead Insurance, Inc.",
  "url": "https://frontierpicks.com/dossiers/GSHD/",
  "json_url": "https://frontierpicks.com/dossiers/GSHD.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Post-print re-rating extended on no new information: the 2026-08-21 close of $72.52 is above UBS's $72, above KBW's $72 and above the ~$71 aggregator consensus, while founder-side Class B conversions sell into it. No dated company catalyst until the Q3 print (~2026-10-21 est.) — the narrative is maturing, not fresh.",
  "invalidation_trigger": "A weekly close below $64 gives back the entire August leg and returns price to the post-print shelf around the $66.29 close of 2026-08-14; secondarily, a Q3 print (~2026-10-21 est.) that trims the 12–19% FY organic band or shows core revenue growth below the +10% Q2 2026 pace as contingent commissions normalize.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "managed-care-health-services",
    "small-cap-value-rotation",
    "housing-homebuilders-proptech"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Up-C structure: consolidated net income differs from the amount attributable to Goosehead Insurance, Inc. Read the attributable line, not the headline.",
    "Class A/Class B structure: founder-side supply arrives via LLC-unit and Class B conversions into Class A, so it never appears as open-market purchase history.",
    "Contingent commissions are lumpy and carrier-profitability dependent — $15.7M in Q2 2026 vs $4.5M a year earlier. Quarter-over-quarter revenue comparisons need this line stripped out.",
    "Sell-side dispersion is unusually wide for a $3B-scale name: one aggregator shows a $43–$125 range across 17 analysts with a 6 Buy / 6 Hold / 1 Sell split."
  ],
  "body_markdown": "## Current Thesis\nThe July binary is a month behind the tape and the re-rating has kept extending on no new information. Goosehead printed Q2 2026 after the close on 2026-07-22: total revenue $113.389M against $103.356M consensus, adjusted EPS $0.64 against $0.48, adjusted EBITDA $37.9M (+30% YoY) at a 33% margin, and a full-year organic revenue-growth band lifted to 12–19% from 10–19%. The last dated headline on the name is UBS raising its target to $72 on 2026-07-27. Since then the only public filings are founder-side unit conversions followed by sales. Price closed at $72.52 on 2026-08-21, against $66.29 on 2026-08-14 and $54.28 on 2026-07-17 — the session before the print. The leg being bought is unchanged: the end of a derate, with margin expansion arriving before revenue reacceleration. What changed in the last week is where price sits relative to the people who publish targets. The 2026-08-21 close is above UBS's $72 (2026-07-27), above the $72 Keefe, Bruyette & Woods cut to on 2026-07-23, and above the roughly $71 aggregator consensus struck across 17 analysts. The next company-generated number lands at the Q3 print, around late October.\n\n## Bull Case\n- Q2 2026 (2026-07-22): revenue $113.389M vs $103.356M consensus, adjusted EPS $0.64 vs $0.48. The move off that print has now been held for a month and extended, rather than round-tripped.\n- Adjusted EBITDA $37.9M, +30% YoY, margin 33% — two points wider YoY. Operating leverage is showing up before any recurring-revenue reacceleration.\n- FY2026 organic total-revenue growth guided to 12–19% at the print, floor raised from 10%; written-premium growth 12–20%. Management tied a second-half acceleration to improving client retention and new-business generation.\n- Scale metrics compounding: total written premium $1.34B (+14%), policies in force ~2.1M (+15%), corporate sales agents 583 (+22% YoY) at 2026-06-30.\n- Buyback executed well below current levels: 95,000 shares repurchased at a $40.95 average during Q2 2026, with $144.6M of authorization remaining at quarter-end.\n- Succession is internal and dated: Mark Jones, Jr. Becomes CEO effective 2027-01-01, Mark Miller retiring 2026-12-31 — announced with the beat on 2026-07-22, not as a separate shock.\n- Price is still 19.0% below the $89.49 52-week high as of the 2026-08-21 close, so the re-rating has not restored the prior peak.\n\n## Bear Case\n- Core revenue grew +10% to $95.6M in Q2 2026, down from +15% in Q1 2026, while total revenue grew 21%. Contingent commissions supplied $15.7M against $4.5M a year earlier — a carrier-profitability-dependent line that does not compound on schedule.\n- The franchise engine is close to static: franchise producers 2,190 (+5% YoY) versus corporate agents +22%. Growth is migrating to a headcount build the company funds itself.\n- Client retention was 86% at Q2 2026. The guided second-half acceleration is explicitly conditioned on that number improving.\n- The sell-side gap has closed and inverted. One aggregator shows a ~$71 average across 17 analysts (6 Buy / 6 Hold / 1 Sell, range $43–$125) against a 2026-08-21 close of $72.52; on 2026-07-17 the same construction implied a wide discount.\n- Founder-side supply is arriving into the advance. A Form 144 filed 2026-08-13 covers 15,000 Class A shares, aggregate market value $983,250, through J.P. Morgan Securities. A Form 4 filed 2026-08-17 shows Serena Jones (10% owner and director) converting LLC units and Class B shares and selling 250 Class A at $67.50 on 2026-08-13, outside a Rule 10b5-1 plan. The pattern is older than this leg: on 2026-05-26 Mark and Robyn Jones and a family trust converted and sold 45,588 Class A at a $40.07 weighted average.\n- Balance sheet is thin as a shock absorber: $23.7M cash and equivalents against $323.0M total notes payable at 2026-06-30.\n\n## Setup & Price Structure\nThe narrative is **maturing**. The dating is straightforward — the informational event was 2026-07-22, the last fresh sell-side action was 2026-07-27, and the move from $66.29 (2026-08-14) to $72.52 (2026-08-21) happened with no company headline and no filing other than insider conversions. Attention is not expanding; price is.\n\nObservable positioning and crowding evidence, without a verdict attached:\n- The 2026-08-21 close of $72.52 sits above the two highest post-print targets published on the name ($72 from UBS on 2026-07-27, $72 from KBW on 2026-07-23) and above the ~$71 aggregator consensus across 17 analysts.\n- RSI(14) at 66.4 on 2026-08-21 — elevated, below the conventional 70 overbought marker.\n- A three-month price change of +74.0% into 2026-08-21, with the stock still 19.0% under the $89.49 52-week high.\n- Insider distribution is confirmed at the small end and noticed at the larger end: 250 shares sold at $67.50 on 2026-08-13 (Form 4, filed 2026-08-17) against a 15,000-share Rule 144 notice filed the same day. The gap between the notice and the confirmed sale is the open question — the notice runs three months.\n- No earnings date inside the next 30 days, so there is no scheduled event to compress or resolve the move.\n\nStructurally, the post-print shelf is the $66.29 area that held from late July into 2026-08-14; the pre-print reference is $54.28 (2026-07-17). The August leg above that shelf is the part with no fundamental news underneath it.\n\n## Catalyst Calendar (next 30 days)\n- **No scheduled company event between 2026-08-23 and 2026-09-22.** Goosehead has not announced a Q3 date; the historical cadence places it around 2026-10-21 (est.), outside this window.\n- **~2026-09-10 (est.)** — climatological peak of the Atlantic hurricane season. Not a company event, but catastrophe severity feeds carrier underwriting profitability, which sets the contingent-commission pool that produced $15.7M in Q2 2026 versus $4.5M a year earlier.\n- **Through ~2026-11-11** — the three-month sale window opened by the 2026-08-13 Form 144 (15,000 Class A shares). Any further Form 4s inside it are dated evidence on whether founder-side supply keeps meeting this price.\n- **~2026-10-21 (est.)** — Q3 2026 print. First test of the 12–19% FY organic band and of whether core revenue holds the +10% Q2 pace as contingents normalize.\n\n## What Would Change Our Mind\nThe structure that matters is the August leg built above the $66.29 shelf on zero company news. Losing that leg entirely — a weekly close below $64 — would put price back inside the post-print consolidation and reframe the last month as a momentum overshoot rather than a durable re-rating; that is the gradeable break. Three non-price observables would do the same work more slowly. First, the Q3 print (~2026-10-21 est.) trimming the 12–19% organic band or the 12–20% written-premium band, or showing core revenue growth below the +10% recorded in Q2 2026 while contingent commissions revert toward the $4.5M prior-year level. Second, retention printing at or below 86% at Q3, which removes the mechanism management named for the second-half acceleration. Third, Form 4s completing the 15,000-share Rule 144 notice at prices above the ~$65.55 implied by its $983,250 aggregate value, alongside further target cuts in the shape of the KBW reduction to $72 on 2026-07-23. On the other side, a Q3 print that holds +10%-or-better core growth with contingents normalized would remove the central objection in this note, since the beat would then be recurring.\n\n## Correlation Notes\n- Peer read-across runs to personal-lines and commercial brokers (BRO, AJG, MMC): the group trades on organic-growth prints and contingent-commission commentary, so a peer flagging softening contingents ahead of Goosehead's Q3 would be an early signal on the same line item.\n- New-business attachment is levered to US home-purchase and mortgage-closing volume, since Goosehead's franchise and corporate agents originate heavily at closing. Slower existing-home turnover shows up in policies-in-force growth before it shows up in revenue — that link is inference from the business model, not a disclosed sensitivity.\n- The contingent line couples the stock to catastrophe outcomes with a lag: a severe Atlantic season damages carrier profitability, which sets contingent payouts recognized in later quarters.\n- As a sub-$3B-cap name that has moved +74.0% in three months, it carries small-cap index beta and is exposed to any unwind in the low-quality/high-beta rotation independent of its own numbers.\n- Softening personal auto and homeowners rate levels compress commission per policy even when policy counts grow; premium growth of +14% at Q2 2026 against policies-in-force growth of +15% is where that pressure would appear first.",
  "first_seen": "2026-06-30",
  "last_analyzed": "2026-08-23T13:10:37+00:00",
  "last_synthesized": "2026-08-23",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}